About NeuroLife

Life Neuroscience (NeuroLife) is an open-access, online, peer-reviewed journal published by Medical Sciences Publications (MedSci) in Germany from January 2023. The publication frequency of NeuroLife is continuous. All articles will be published immediately after acceptance under one VOLUME annually. 

All research articles submitted to NeuroLife should be original, never previously published in any journal or presented at a conference or undergoing such process globally. All the submissions will be peer-reviewed by the panel of experts associated with particular field. Submitted papers should meet the internationally accepted criteria, and manuscripts should follow the journal's style for reviewing and editing. NeuroLife is a principle member subscribing to the International Committee of Medical Journal Editors and World Association of Medical Editors. We follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, issued by International Committee for Medical Journal Editors (ICMJE), as well as the Committee on Publication Ethics (COPE) code of conduct for editors. NeuroLife's ethical policy is based on the Committee on Publication Ethics (COPE) guidelines and complies with the International Committee of Medical Journal Editors (ICMJE) codes of conduct. The following guidelines should be in line with the journal’s guide for authors. Readers, authors, reviewers, and editors should follow these ethical policies once working with NeuroLife.




CAPTCHA
View: 5729 Time(s)   |   Print: 760 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)


© 2024 CC BY-NC 4.0 | Life Neuroscience